Table 2.

Occurrence and relative risks of autoimmune/inflammatory diseases among first-degree relatives of patients with Wegener’s granulomatosis (WG) and among first-degree relatives of matched general population controls. Except for total numbers, data are hazard ratio and 95% CI.

Disease (ICD10)Total Number of Affected Relatives/ControlsChildrenSiblingsParentsAll Biological First-degree RelativesSpouses
Any autoimmune/inflammatory disease*345/26971.30 (1.12–1.51)1.32 (1.04–1.67)1.42 (1.07–1.89)1.32 (1.18–1.49)1.02 (0.67–1.55)
Hypothyroidism (E03)17/1340.96 (0.44–2.09)0.99 (0.36–2.74)3.66 (1.43–9.37)1.31 (0.79–2.17)0.65 (0.09–4.94)
Hyperthyroidism (E05)19/1801.16 (0.64–2.11)1.59 (0.67–3.76)0.30 (0.04–2.19)1.08 (0.68–1.73)1.04 (0.25–4.43)
Insulin-dependent diabetes (E10)57/5121.14 (0.80–1.62)0.85 (0.45–1.60)1.76 (0.98–3.16)1.16 (0.89–1.52)1.91 (0.85–4.29)
Multiple sclerosis (G35)18/972.06 (1.16–3.65)1.11 (0.26–4.64)2.55 (0.55–11.82)1.92 (1.16–3.16)2.42 (0.52–11.21)
Crohn’s disease (K50)18/1301.50 (0.82–2.75)1.01 (0.31–3.28)1.76 (0.51–6.09)1.42 (0.87–2.33)1.12 (0.15–8.64)
Ulcerative colitis (K51)32/2871.12 (0.71–1.78)1.37 (0.61–3.04)0.94 (0.22–4.02)1.15 (0.79–1.70)**
Psoriatic arthritis (L40.5)72/5311.24 (0.89–1.73)1.57 (1.01–2.44)1.82 (0.95–3.49)1.41 (1.10–1.81)1.34 (0.62–2.93)
All inflammatory polyarthritis combined74/5141.66 (1.11–2.49)2.04 (1.15–3.62)0.88 (0.46–1.67)1.45 (1.12–1.87)0.60 (0.19–1.93)
  Rheumatoid arthritis RF+ (M05)38/2491.41 (0.84–2.38)2.50 (1.42–4.41)0.87 (0.38–2.02)1.54 (1.09–2.19)0.57 (0.08–4.26)
  Rheumatoid arthritis RF– (M06)12/1151.41 (0.68–2.95)0.35 (0.05–2.59)1.11 (0.34–3.66)1.07 (0.59–1.94)1.19 (0.15–9.33)
  Other inflammatory polyarthritis (M13)24/1641.72 (1.04–2.85)1.79 (1.10–2.91)0.55 (0.07–4.13)1.56 (1.01–2.43)0.43 (0.06–3.11)
Sjögren’s syndrome (M35.0)12/612.36 (0.97–5.72)1.49 (0.45–4.99)2.15 (0.60–7.73)2.00 (1.07–3.73)**
Systemic lupus erythematosus (M32)7/421.85 (0.72–4.77)**3.69 (0.69–19.85)1.71 (0.77–3.80)**
WG (M31.3)4/142.60 (0.56–12.04)2.10 (0.25–17.46)**2.98 (0.99–8.97)**
Ankylosing spondylitis (M45)10/612.14 (0.92–4.97)1.75 (0.41–7.45)**1.69 (0.81–3.50)**
  • * Juvenile rheumatoid arthritis, unspecified spondylitis, and Hashimoto thyroiditis, n = 5, are not analyzed separately but included in “any.”

  • ** Too few events to calculate hazard ratio and CI.